Johnson S J, Hosford-Dunn H, Paryani S, Yeager A, Malachowski N
Ear Hear. 1986 Oct;7(5):325-7. doi: 10.1097/00003446-198610000-00007.
Audiologic follow-up was obtained on 40 premature or sick term infants with perinatally acquired cytomegalovirus (CMV) infection and on 40 prospectively matched control subjects. Final evaluation was postponed until 3 years of age to assess any long-term hearing sequelae of perinatal CMV infection in this population, and to obtain reasonably complete audiometric results. One experimental subject had a bilateral sensorineural hearing loss above 4000 Hz. Four control subjects had sensorineural hearing losses, three requiring binaural hearing aids. The prevalence of confirmed hearing loss requiring amplification (3.75%) in this study group was consistent with that observed in all graduates of the Intensive Care Nursery who were considered at risk for hearing loss in the same time period (4.2%). These data suggest that perinatally acquired CMV infection is not associated with significant sensorineural hearing loss in premature or full term infants through age 3.
对40例围产期获得性巨细胞病毒(CMV)感染的早产或患病足月儿以及40例前瞻性匹配的对照受试者进行了听力学随访。最终评估推迟至3岁,以评估该人群围产期CMV感染的任何长期听力后遗症,并获得合理完整的听力测试结果。一名实验对象在4000Hz以上有双侧感音神经性听力损失。四名对照受试者有感音神经性听力损失,三名需要双耳助听器。该研究组中确诊需要放大听力损失的患病率(3.75%)与同期被认为有听力损失风险的重症监护病房所有毕业生中观察到的患病率(4.2%)一致。这些数据表明,在3岁之前,围产期获得性CMV感染与早产或足月婴儿的显著感音神经性听力损失无关。